Stock listing

NASDAQ:CHRS Coherus Oncology, Inc. Stock

Home listing (NASDAQ) of Coherus Oncology, Inc.

Follow Coherus Oncology, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:CHRS

$1.00 USD +0.04 (+4.3%)

Close on Oct 20, 2026

Past 3 months -35.9% · daily closes, Jul 6, 2026 – Oct 20, 2026, adjusted for splits
Day range
$0.955 – $1.03 USDOct 20, 2026
Volume
967,662 sharesOct 20, 2026
Market cap
$154.5M USDAt the close on Oct 20, 2026 · price × 154.5M shares outstanding
Coherus Oncology, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:CHRS · Home$1.00 USD+0.041 (+4.3%)967,662$0.96$1.03$0.955$0.959Close on Oct 20, 2026
Frankfurt:8C5€0.84 EUR-0.049 (-5.5%)—€0.84€0.84€0.84€0.889Close on Oct 20, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 20, 2026 · NASDAQ:CHRS · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$1.00+0.041+4.3%$0.96$1.03$0.955967,662
$0.959-0.031-3.2%$1.00$1.015$0.9411,726,152
$0.99-0.08-7.5%$1.07$1.07$0.987938,496
$1.07+0.02+1.9%$1.07$1.09$1.031,541,487
$1.05-0.02-1.9%$1.05$1.085$1.0111,716,202
$1.07+0.04+3.9%$1.06$1.08$1.001,342,018
$1.03-0.04-3.7%$1.06$1.066$1.031,035,887
$1.070.000.0%$1.06$1.12$1.051,697,095
$1.07+0.06+5.9%$1.01$1.07$0.9742,141,504
$1.01-0.02-1.9%$1.02$1.08$1.011,234,370
$1.03-0.09-8.0%$1.13$1.13$1.012,965,300
$1.12-0.04-3.4%$1.16$1.16$1.082,008,500
$1.160.000.0%$1.19$1.19$1.1451,183,200
$1.16-0.05-4.1%$1.20$1.21$1.145709,200
$1.21+0.03+2.5%$1.18$1.23$1.1551,579,800
$1.18+0.04+3.5%$1.15$1.20$1.121,346,800
$1.14+0.01+0.9%$1.13$1.15$1.101,143,300
$1.13-0.04-3.4%$1.17$1.185$1.131,221,400
$1.17-0.09-7.1%$1.25$1.265$1.171,561,600
$1.26-0.04-3.1%$1.30$1.31$1.211,615,700
$1.30-0.07-5.1%$1.39$1.39$1.224,535,100
$1.37+0.02+1.5%$1.35$1.43$1.301,489,500
$1.35+0.12+9.8%$1.23$1.35$1.2253,121,100
$1.23+0.01+0.8%$1.26$1.27$1.181,885,500
$1.22-0.11-8.3%$1.34$1.35$1.211,289,600
$1.33-0.10-7.0%$1.38$1.39$1.32762,000
$1.43+0.10+7.5%$1.34$1.43$1.341,274,900
$1.33-0.01-0.7%$1.378$1.38$1.325529,200
$1.34+0.02+1.5%$1.33$1.36$1.301,019,100
$1.32-0.05-3.6%$1.34$1.375$1.31840,600
$1.37-0.05-3.5%$1.40$1.43$1.36549,200
$1.42+0.05+3.6%$1.38$1.435$1.38304,100
$1.37-0.05-3.5%$1.42$1.43$1.36437,200
$1.42+0.05+3.6%$1.37$1.435$1.355621,400
$1.37+0.02+1.5%$1.36$1.40$1.35695,100
$1.35-0.06-4.3%$1.39$1.41$1.301,127,700
$1.41-0.05-3.4%$1.45$1.48$1.40604,800
$1.46+0.01+0.7%$1.43$1.48$1.41788,300
$1.45+0.08+5.8%$1.37$1.455$1.34896,500
$1.37+0.01+0.7%$1.36$1.41$1.311,297,214
$1.36-0.06-4.2%$1.43$1.43$1.351,046,359
$1.42+0.10+7.6%$1.32$1.44$1.3151,565,300
$1.32-0.01-0.8%$1.31$1.34$1.27740,200
$1.33-0.01-0.7%$1.379$1.405$1.2953,038,100
$1.34+0.19+16.5%$1.26$1.36$1.223,477,700
$1.15-0.05-4.2%$1.20$1.20$1.131,264,600
$1.20+0.06+5.3%$1.16$1.205$1.14648,300
$1.14-0.03-2.6%$1.18$1.195$1.131,060,000
$1.17-0.04-3.3%$1.21$1.246$1.171,155,500
$1.21-0.03-2.4%$1.25$1.26$1.18968,300
$1.24-0.03-2.4%$1.33$1.34$1.23978,100
$1.27+0.005+0.4%$1.27$1.40$1.241,600,200
$1.265-0.185-12.8%$1.385$1.455$1.1313,721,800
$1.45-0.03-2.0%$1.48$1.525$1.435999,300
$1.48+0.04+2.8%$1.43$1.50$1.43617,700
$1.44+0.03+2.1%$1.42$1.459$1.414477,300
$1.41-0.06-4.1%$1.48$1.48$1.40436,900
$1.47+0.06+4.3%$1.42$1.485$1.415508,900
$1.41-0.03-2.1%$1.44$1.475$1.40570,900
$1.44-0.02-1.4%$1.46$1.47$1.415387,600
$1.46+0.05+3.5%$1.46$1.495$1.44456,100
$1.41-0.02-1.4%$1.44$1.445$1.395446,400
$1.430.000.0%$1.42$1.45$1.395439,300
$1.43-0.04-2.7%$1.48$1.485$1.425349,800
$1.47+0.05+3.5%$1.43$1.48$1.40376,600
$1.42+0.02+1.4%$1.39$1.435$1.38365,400
Ticker
NASDAQ:CHRS
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Coherus Oncology (NASDAQ:CHRS) Q2 2026 Earnings Call

    Wed, Aug 05, 2026 · 5:00 PM ET

    Watch Transcript

  • Coherus Oncology (NASDAQ:CHRS) Q1 2026 Earnings Call

    Mon, May 11, 2026 · 5:00 PM ET

    Watch Transcript

  • Coherus Oncology (NASDAQ:CHRS) Q4 2025 Earnings Call

    Mon, Mar 09, 2026 · 4:30 PM ET

    Watch Transcript

Latest news

Coherus Oncology to Host Webcast to Disclose Interim Tagmokitug Clinical Data on October 28, 2026

Oct 14, 2026

Closed $1.07 (+1.9%) on Oct 15, 2026

Coherus Oncology Retains Oppenheimer & Co. to Market Legacy BioSimilar Assets

Sep 23, 2026

Closed $1.26 (-3.1%) on Sep 23, 2026

Coherus Oncology Announces Special Dividend of Biosimilar Contingent Value Rights

Aug 17, 2026

Closed $1.34 (+16.5%) on Aug 18, 2026

Coherus Oncology Reports Second Quarter 2026 Financial Results and Provides Business Update

Aug 5, 2026

Closed $1.27 (-12.8%) on Aug 6, 2026

Coherus Oncology to Report Second Quarter 2026 Financial Results on August 5, 2026

Jul 22, 2026

Closed $1.43 (-2.7%) on Jul 22, 2026

Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi)

Jun 23, 2026

Coherus Oncology Reports First Quarter 2026 Financial Results and Provides Business Update

May 11, 2026

Coherus Oncology to Report First Quarter 2026 Financial Results on May 11, 2026

May 4, 2026

Coherus Oncology Reports Full Year and Fourth Quarter 2025 Financial Results and Provides Business Update

Mar 9, 2026

Coherus Oncology to Report Full Year and Fourth Quarter 2025 Financial Results on March 9, 2026

Mar 2, 2026

All Coherus Oncology, Inc. news

Decks

Coherus Oncology, Inc. on 6ix

News releases
22 in the last 12 months · 156 in all · newest Oct 14, 2026 · oldest 2019
Calls
23 calls with a replay · 23 with a transcript · latest Aug 5, 2026
Decks
4 decks · latest September 2026

Where Coherus Oncology, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:CHRS · Home listing · This pageNASDAQUnited StatesUSD
Tradegate:8C5TradegateGermanyEUR
gettex:8C5gettexGermanyEUR
Lang & Schwarz:A12ETZLang & SchwarzGermanyEUR
LS Exchange:A12ETZLS ExchangeGermanyEUR
BOATS:CHRSBOATSUnited StatesUSD
BX Swiss:8C5BX SwissSwitzerlandCHF
Dusseldorf:8C5DusseldorfGermanyEUR
Frankfurt:8C5FrankfurtGermanyEUR
Munich:8C5MunichGermanyEUR
Stuttgart:8C5StuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Coherus Oncology, Inc.